Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Q: How much funding does Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) provide?

Funding amounts vary. Check the grant details for specifics.

Q: When is the deadline for Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)?

The deadline is November 2, 2028.

National Institutes of Health

Federal Grants for Science Research Healthcare Grants

Apply Now

Funding Amount

Varies

Deadline

November 2, 2028

939 days left

Grant Type

federal

Overview

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials including efficacy, comparative effectiveness, pragmatic and/or dissemination and implementation science clinical trials. Trials using innovative designs such as platform trials, adaptive, and Bayesian designs are encouraged. These trials may include ones that test different therapeutic, behavioral, dissemination and implementation science clinical trials and/or prevention strategies.Trials for which this NOFO applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the NHLBI website.This NOFO will utilize a bi-phasic, milestone-driven cooperative agreement mechanism of award and runs in parallel with a companion NOFO for a collaborating Data Coordinating Center (PAR-27-013). The objective of the CCC application is to present the scientific rationale for the clinical trial and a comprehensive scientific and operational plan that describes it. The application should address project management, subject recruitment and retention, performance milestones, scientific conduct of the trial, and dissemination of results. The application should also describe its approaches to increasing community engagement from conceptual design of the intervention through implementation and sustainability and close gaps in health outcomes within the US population and increase health for all.Both a CCC application and a collaborating Data Coordinating Center (DCC) application must be submitted on the same application due date for consideration by NHLBI. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact prior to submitting an application.

Details

Agency: National Institutes of Health
Department: Department of Health and Human Services
Opportunity #: PAR-27-012
Instrument: cooperative_agreement

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resu

Eligibility

Eligible Applicant Types

public_and_state_institutions_of_higher_educationindependent_school_districtsstate_governmentscity_or_township_governmentsnonprofits_non_higher_education_with_501c3special_district_governmentspublic_and_indian_housing_authoritiesprivate_institutions_of_higher_educationsmall_businessesother_native_american_tribal_organizationsnonprofits_non_higher_education_without_501c3county_governmentsfederally_recognized_native_american_tribal_governmentsfor_profit_organizations_other_than_small_businessesother

How to Apply

PAR-27-012-Full-Announcement.html

<!DOCTYPE html>
<html lang="en">
<head>
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
<link href='../../../images/grantsolutions/favicon.ico' rel='icon'></link>
<link rel="stylesheet" href="https://grants.nih.gov/grants/guide/pa-files/css/bootstrap.min.css"></link>
<link rel="stylesheet" href="https://grants.nih.gov/grants/guide/guide_styles/css/style.css"></link>
<script src=''></script>
<style>
a {
color: #1F6BB2 !important;
}
table#keyDatesContentTable tbody tr:last-child {
border-bottom: 2px solid #bcbcbc;
}
table#keyDatesContentTable tbody tr td:nth-child(3),
table#keyDatesContentTable tbody tr td:nth-child(6) {
border-right:2px solid #bcbcbc;
}
table#keyDatesContentTable tbody tr td:first-child {
border-left:2px solid #bcbcbc;
}

figure.table table{
width: 100%;
height: 100%;
}
.table thead>tr>th,
.table tbody>tr>th,
.table tfoot>tr>th,
.table thead>tr>td,
.table tbody>tr>td,
.table tfoot>tr>td,
figure.table table,
figure.table th,
figure.table tr,
figure.table td {
border: 1px solid rgb(0, 0, 0);
border-spacing: 0;
}

</style>
<style> .ck-indent-1{ margin-left:25px; } .ck-indent-2{ margin-left:50px; } .ck-indent-3{ margin-left:75px; } .ck-indent-4{ margin-left:100px; } .ck-indent-5{ margin-left:125px; } .ck-indent-6{ margin-left:150px; } .ck-indent-7{ margin-left:175px; } .ck-indent-8{ margin-left:200px; } .ck-indent-9{ margin-left:225px; } .ck-indent-10{ margin-left:250px; } .ck-indent-11{ margin-left:275px; } .ck-indent-12{ margin-left:300px; } .ck-indent-13{ margin-left:325px; } .ck-indent-14{ margin-left:350px; } .ck-indent-15{ margin-left:375px; } .ck-indent-16{ margin-left:400px; } .ck-indent-17{ margin-left:425px; } .ck-indent-18{ margin-left:450px; } .ck-indent-19{ margin-left:475px; } .ck-indent-20{ margin-left:500px; } </style>
<title>PAR-27-012: Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)</title>

<script>
function initContent() {
if (typeof window.jQuery == 'undefined') {
return;
}

// Init headings
for (i=1; i<5; i++) {
$('h'+i).each(function(index, element) {
$(element).replaceWith('<div class="heading'+i+'">'+$(element).html()+'</div>');
});
}

// Init links so they open in new window
$('a').each(function(index, element) {
if ($(element).attr('href') && $(element).attr('href').indexOf('http') >= 0) {
$(element).attr('target','_blank');
}
});

}

</script>

</head>
<body onload="initContent()">
<div class="container">
<div class="row">
<div id="page-title" class="heading1" tabindex="0">Department of Health and Human Services</div>

<div>

<div data-element-id="261213" data-element-has-label="false" data-element-required="false" data-element-has-value="true" data-section-code="OI" data-element-type="TEXT">
<a id='_bookmark261213' tabindex='-1' aria-hidden='true'></a><a name="_Part 1. Overview Information"></a><h1>Part 1. Overview Information</h1>
</div>

<div class="row" data-index="2">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261214" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="TEXT">
<a id='_bookmark261214' tabindex='-1' aria-hidden='true'></a>Participating Organization(s)
</div>
<div class=" col-md-8 datacolumn">
<p>National Institutes of Health (<a href="http://www.nih.gov">NIH</a>)</p>
</div>
</div>

<div class="row" data-index="4">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261216" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="LINKED_ELEMENT">
<a id='_bookmark261216' tabindex='-1' aria-hidden='true'></a>Components of Participating Organizations
</div>
<div class=" col-md-8 datacolumn">
<p>National Heart, Lung, and Blood Institute (<a href="https://www.nhlbi.nih.gov/" target="_blank" rel="noreferrer">NHLBI</a>)
</div>
</div>

<div class="row" data-index="6">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261218" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="LINKED_ELEMENT">
<a id='_bookmark261218' tabindex='-1' aria-hidden='true'></a>Funding Opportunity Title
</div>
<div class=" col-md-8 datacolumn">
<span class="title">Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)</span>
</div>
</div>

<div class="row" data-index="7">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261219" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="TEXT">
<a id='_bookmark261219' tabindex='-1' aria-hidden='true'></a>Activity Code
</div>
<div class=" col-md-8 datacolumn">
<p><a href="http://grants.nih.gov/grants/funding/ac_search_results.htm?text_curr=ug3&Search.x=0&Search.y=0&Search_Type=Activity">UG3</a>/<a href="http://grants.nih.gov/grants/funding/ac_search_results.htm?text_curr=uh3&Search.x=0&Search.y=0&Search_Type=Activity">UH3</a> Exploratory/Developmental Phased Award Cooperative Agreement</p>
</div>
</div>

<div class="row" data-index="8">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261220" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="LINKED_ELEMENT">
<a id='_bookmark261220' tabindex='-1' aria-hidden='true'></a>Announcement Type
</div>
<div class=" col-md-8 datacolumn">
Reissue of

PAR-25-029

<br/>
</div>
</div>

<div class="row" data-index="9">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261221" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="TEXT">
<a id='_bookmark261221' tabindex='-1' aria-hidden='true'></a>Related Notices
</div>
<div class=" col-md-8 datacolumn">
<ul><li>Check for any recent <a href="https://grants.nih.gov/grants/guide/url_redirect.php?id=11163">Notices of NIH Policy Changes</a> that may impact application requirements.</li></ul>
</div>
</div>

<div class="row" data-index="10">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261222" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="LINKED_ELEMENT">
<a id='_bookmark261222' tabindex='-1' aria-hidden='true'></a>Funding Opportunity Number (FON)
</div>
<div class=" col-md-8 datacolumn">
<span class="noticenum">PAR-27-012</span>
</div>
</div>

<div class="row" data-index="11">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261223" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="LINKED_ELEMENT">
<a id='_bookmark261223' tabindex='-1' aria-hidden='true'></a>Companion Funding Opportunity
</div>
<div class=" col-md-8 datacolumn">
<a href="https://www.grants.gov/search-results-detail/358938" target="_blank" rel="noreferrer">PAR-27-013</a>

<span class="separator" style="position:relative;left:-3px">,</span> <a href="https://grants.nih.gov/grants/funding/ac_search_results.htm?text_curr=U24&&Search.x=0&&Search.y=0&&Search_Type=Activity" target="_blank" rel="noreferrer">U24</a>
Resource-Related Research Project (Cooperative Agreements)

<br/>
</div>
</div>

<div class="row" data-index="12">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261224" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="TEXT">
<a id='_bookmark261224' tabindex='-1' aria-hidden='true'></a>Number of Applications
</div>
<div class=" col-md-8 datacolumn">
<p>See Section III. 3. Additional Information on Eligibility.</p>
</div>
</div>

<div class="row" data-index="13">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261225" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="LINKED_ELEMENT">
<a id='_bookmark261225' tabindex='-1' aria-hidden='true'></a>Assistance Listing Number(s)
</div>
<div class=" col-md-8 datacolumn">
93.837, 93.233, 93.838, 93.839, 93.840
</div>
</div>

<div class="row" data-index="14">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261226" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="TEXT">
<a id='_bookmark261226' tabindex='-1' aria-hidden='true'></a>Funding Opportunity Purpose
</div>
<div class=" col-md-8 datacolumn">
<p>This Notice of Funding Opportunity (NOFO) supports applications to develop and conduct a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials including efficacy, comparative effectiveness, pragmatic and/or dissemination and implementation science clinical trials. Trials using innovative designs such as platform trials, adaptive, and Bayesian designs are encouraged. These trials may include ones that test different therapeutic, behavioral, dissemination and implementation science clinical trials and/or prevention strategies.Trials for which this NOFO applies must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see <a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-015.html">NOT-OD-15-015</a>). For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the <a href="https://www.nhlbi.nih.gov/">NHLBI website</a>.<br><br>This NOFO will utilize a bi-phasic, milestone-driven cooperative agreement mechanism of award and runs in parallel with a companion NOFO for a collaborating Data Coordinating Center (<a href="https://grants.nih.gov/grants/guide/pa-files/PAR-26-024.html">PAR-27-013</a>). The objective of the CCC application is to present the scientific rationale for the clinical trial and a comprehensive scientific and operational plan that describes it. The application should address project management, subject recruitment and retention, performance milestones, scientific conduct of the trial, and dissemination of results. The application should also describe its approaches to increasing community engagement from conceptual design of the intervention through implementation and sustainability and close gaps in health outcomes within the US population and increase health for all.<br><br>Both a CCC application and a collaborating Data Coordinating Center (DCC) application must be submitted on the same application due date for consideration by NHLBI. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact prior to submitting an application.</p>
</div>
</div>

<div class="row" data-index="16">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261228" data-element-required="true" data-element-has-value="true" data-section-code="OI" data-element-type="TEXT">
<a id='_bookmark261228' tabindex='-1' aria-hidden='true'></a>Funding Opportunity Goal(s)
</div>
<div class=" col-md-8 datacolumn">
<p>The Division of Cardiovascular Sciences supports research and training to foster heart and vascular research in the basic, translational, clinical and population sciences, and to foster training to build talented young investigators in these areas, funded through competitive research training grants.</p><p>The Division of Lung Diseases supports research and research training on the causes, diagnosis, prevention, and treatment of lung diseases and sleep disorders.</p><p>The Division of Blood Diseases and Resources supports and research and training to foster research and research training on the pathophysiology, diagnosis, treatment, and prevention of non-neoplastic blood diseases, including anemias, sickle cell disease, thalassemia; biology of red blood cells, white blood cells, and platelets, hematopoietic stem cells and the bone marrow niche, hemophilia and other abnormalities of hemostasis and thrombosis.</p><p>The Center for Translation Research and Implementation Science (CTRIS) plans, fosters, and supports late-stage research to identify promising approaches for ensuring successful integration of evidence and evidence-based interventions within clinical and public health settings, such as health centers, worksites, schools, and communities in the United States and abroad.</p><p>The National Center on Sleep Disorders Research (NCSDR) supports research and research training related to sleep disordered breathing, and the fundamental functions of sleep and circadian rhythms.</p>
</div>
</div>

<div data-element-id="261229" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="KD" data-element-type="TEXT">
<a id='_bookmark261229' tabindex='-1' aria-hidden='true'></a><a name="_Key Dates"></a><h2>Key Dates</h2>
</div>

<div class="row" data-index="18">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261230" data-element-required="true" data-element-has-value="true" data-section-code="KD" data-element-type="DATE">
<a id='_bookmark261230' tabindex='-1' aria-hidden='true'></a>Posted Date
</div>
<div class=" col-md-8 datacolumn">
March 18, 2026
</div>
</div>

<div class="row" data-index="19">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261231" data-element-required="true" data-element-has-value="true" data-section-code="KD" data-element-type="LINKED_ELEMENT">
<a id='_bookmark261231' tabindex='-1' aria-hidden='true'></a>Open Date (Earliest Submission Date)
</div>
<div class=" col-md-8 datacolumn">
May 02, 2026
</div>
</div>

<div data-element-id="261233" data-element-has-label="false" data-element-required="false" data-element-has-value="true" data-section-code="KD" data-element-type="LINKED_ELEMENT">
<a id='_bookmark261233' tabindex='-1' aria-hidden='true'></a>
<table class="table table-bordered table-striped table-hover eraDataTable" id="keyDatesContentTable">
<thead>
<tr>
<th scope="col" colspan="3" style="border:2px solid #bcbcbc;" class="text-center">Application Due Dates</th>
<th scope="col" colspan="3" style="border:2px solid #bcbcbc;" class="text-center">Review and Award Cycles</th>
</tr>
<tr>
<th scope="col" style="width:16.66%;border-left:2px solid #bcbcbc;" class="text-center">New</th>
<th scope="col" style="width:16.66%" class="text-center">Renewal / Resubmission / Revision (as allowed)</th>
<th scope="col" style="width:16.66%;border-right:2px solid #bcbcbc;" class="text-center">AIDS - New/Renewal/Resubmission/Revision, as allowed</th>
<th scope="col" style="width:16.66%" class="text-center">Scientific Merit Review</th>
<th scope="col" style="width:16.66%" class="text-center">Advisory Council Review</th>
<th scope="col" style="width:16.66%;border-right:2px solid #bcbcbc;" class="text-center">Earliest Start Date</th>
</tr>
</thead>
<tbody>
<tr>
<td>
June 02, 2026
</td>
<td>
July 02, 2026
</td>
<td>
Not Applicable
</td>
<td>November 2026</td>
<td> January 2027

</td>
<td>April 2027</td>
</tr>
<tr>
<td>
October 02, 2026
</td>
<td>
November 02, 2026
</td>
<td>
Not Applicable
</td>
<td>March 2027</td>
<td> May 2027

</td>
<td>July 2027</td>
</tr>
<tr>
<td>
February 01, 2027
</td>
<td>
March 01, 2027
</td>
<td>
Not Applicable
</td>
<td>July 2027</td>
<td> October 2027

</td>
<td>December 2027</td>
</tr>
<tr>
<td>
June 02, 2027
</td>
<td>
July 02, 2027
</td>
<td>
Not Applicable
</td>
<td>November 2027</td>
<td> January 2028

</td>
<td>April 2028</td>
</tr>
<tr>
<td>
October 01, 2027
</td>
<td>
November 01, 2027
</td>
<td>
Not Applicable
</td>
<td>March 2028</td>
<td> May 2028

</td>
<td>July 2028</td>
</tr>
<tr>
<td>
February 01, 2028
</td>
<td>
March 01, 2028
</td>
<td>
Not Applicable
</td>
<td>July 2028</td>
<td> October 2028

</td>
<td>December 2028</td>
</tr>
<tr>
<td>
June 01, 2028
</td>
<td>
June 30, 2028
</td>
<td>
Not Applicable
</td>
<td>November 2028</td>
<td> January 2029

</td>
<td>April 2029</td>
</tr>
<tr>
<td>
October 02, 2028
</td>
<td>
November 02, 2028
</td>
<td>
Not Applicable
</td>
<td>March 2029</td>
<td> May 2029

</td>
<td>July 2029</td>
</tr>
</tbody>
</table>
</div>

<div data-element-id="261235" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="KD" data-element-type="TEXT">
<a id='_bookmark261235' tabindex='-1' aria-hidden='true'></a><p>All applications are due by 5:00 PM local time of applicant organization. </p>

<p>Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.</p>
</div>

<div class="row" data-index="28">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261241" data-element-required="true" data-element-has-value="true" data-section-code="KD" data-element-type="TEXT">
<a id='_bookmark261241' tabindex='-1' aria-hidden='true'></a>Due Dates for E.O. 12372
</div>
<div class=" col-md-8 datacolumn">
<p>Not Applicable</p>
</div>
</div>

<div class="row" data-index="29">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261242" data-element-required="true" data-element-has-value="true" data-section-code="KD" data-element-type="LINKED_ELEMENT">
<a id='_bookmark261242' tabindex='-1' aria-hidden='true'></a>Expiration Date
</div>
<div class=" col-md-8 datacolumn">
November 03, 2028
</div>
</div>

<div class="heading4" tabindex="0" data-element-id="261243" data-element-required="true" data-element-has-value="true" data-section-code="KD" data-element-type="TEXT">
<a id='_bookmark261243' tabindex='-1' aria-hidden='true'></a>Required Application Instructions
</div>

<div data-element-id="261243" data-element-has-label="true" data-element-required="true" data-element-has-value="true" data-section-code="KD" data-element-type="TEXT">
<p>It is critical that applicants follow the instructions in the Research (R) Instructions in the <a href="https://grants.nih.gov/grants/guide/url_redirect.htm?id=82400">How to Apply - Application Guide</a>, except where instructed to do otherwise (in this NOFO or in a Notice from <a href="http://grants.nih.gov/grants/guide/url_redirect.htm?id=11164">NIH Guide for Grants and Contracts</a>).</p>

<p>Conformance to all requirements (both in the Application Guide and the NOFO) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.</p>

<p><strong>Applications that do not comply with these instructions may be delayed or not accepted for review.</strong></p>
</div>

<div data-element-id="262235" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="KD" data-element-type="TEXT">
<a id='_bookmark262235' tabindex='-1' aria-hidden='true'></a><p style="margin-left:0in;">There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You <strong>must</strong> use one of these submission options to access the application forms for this opportunity.</p><ol><li>Use the <a href="https://public.era.nih.gov/assist/landing.era?tabId=0819b5fc-46b7-4f02-b6b7-127e5a4e19fa">NIH ASSIST system</a> to prepare, submit and track your application online.</li><li>Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants.gov and <a href="https://public.era.nih.gov/commons/">eRA Commons</a> to track your application. Check with your institutional officials regarding availability.</li><li>Use <a href="https://grants.gov/search-grants?oppStatuses=closed|archived|posted|forecasted&fon=PA-25-301">Grants.gov</a> Workspace to prepare and submit your application and <a href="http://public.era.nih.gov/commons/">eRA Commons</a> to track your application.</li></ol>
</div>

<div id="tocDiv">
<div class="heading1" tabindex="0">Table of Contents</div>
<div class="toc-link"><a href="#_Part%201.%20Overview%20Information">Part 1. Overview Information</a></div><div class="toc-link P_SingleIndent"><a href="#_Key%20Dates">Key Dates</a></div><div class="toc-link"><a href="#_Part%202.%20Full%20Text%20of%20Announcement">Part 2. Full Text of Announcement</a></div><div class="toc-link P_SingleIndent"><a href="#_Section%20I.%20Notice%20of%20Funding%20Opportunity%20Description">Section I. Notice of Funding Opportunity Description</a></div><div class="toc-link P_SingleIndent"><a href="#_Section%20II.%20Award%20Information">Section II. Award Information</a></div><div class="toc-link P_SingleIndent"><a href="#_Section%20III.%20Eligibility%20Information">Section III. Eligibility Information</a></div><div class="toc-link P_SingleIndent"><a href="#_Section%20IV.%20Application%20and%20Submission%20Information">Section IV. Application and Submission Information</a></div><div class="toc-link P_SingleIndent"><a href="#_Section%20V.%20Application%20Review%20Information">Section V. Application Review Information</a></div><div class="toc-link P_SingleIndent"><a href="#_Section%20VI.%20Award%20Administration%20Information">Section VI. Award Administration Information</a></div><div class="toc-link P_SingleIndent"><a href="#_Section%20VII.%20Agency%20Contacts">Section VII. Agency Contacts</a></div><div class="toc-link P_SingleIndent"><a href="#_Section%20VIII.%20Other%20Information">Section VIII. Other Information</a></div>
</div><br/>

<div data-element-id="261245" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="FOD" data-element-type="TEXT">
<a id='_bookmark261245' tabindex='-1' aria-hidden='true'></a><a name="_Part 2. Full Text of Announcement"></a><h1>Part 2. Full Text of Announcement</h1>
</div>

<div data-element-id="261246" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="FOD" data-element-type="TEXT">
<a id='_bookmark261246' tabindex='-1' aria-hidden='true'></a><a name="_Section I. Notice of Funding Opportunity Description"></a><h2>Section I. Notice of Funding Opportunity Description</h2>
</div>

<div data-element-id="261247" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="FOD" data-element-type="TEXT">
<a id='_bookmark261247' tabindex='-1' aria-hidden='true'></a><p><strong>NOFO Research Objectives</strong></p><p>This NOFO supports applications to develop and conduct a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials. Clinical trials supported by this NOFO include Phase II and above clinical trials that will enroll participants from two or more recruitment sites. Applications that propose to leverage resources and infrastructure of active clinical trial networks are also supported by this NOFO. This NOFO will utilize a bi-phasic (UG3/UH3), milestone-driven mechanism consisting of a start-up phase of up to one year (UG3) and a full enrollment and clinical trial execution phase (UH3). Applicants must address objectives for both a UG3 and a UH3 phase and are strongly encouraged to use project management principles, as appropriate. </p><p>Proposed research may utilize a design anywhere along the continuum of efficacy, effectiveness, pragmatic and/or dissemination and implementation research clinical trials. For this NOFO, pragmatic trials are considered those that test an intervention under the usual clinical conditions in which it will be applied, while efficacy trials do so under more idealized circumstances. Implementation trials test strategies to adopt and integrate evidence-based health interventions and change practice patterns within specific settings. These implementation trials can include hybrid implementation/effectiveness studies. Innovative trial designs such as adaptive designs will be considered. The trial design should be appropriate for the study question. Trials for which this NOFO applies are expected to contribute to the evidence base for important health matters of relevance to the research mission of NHLBI, close gaps in health outcomes within the US population and increase health for all. For additional information about the mission, strategic vision, and research priorities of the NHLBI, applicants are encouraged to consult the <a href="https://www.nhlbi.nih.gov/">NHLBI website</a>.</p><p>A key characteristic of this NOFO is completion of core milestones. A core milestone is defined as a scheduled event in the project timeline that signifies the completion of a major project stage or activity. Milestones must be performance-based to achieve completion of the trial on time and on budget, and must be established for both the UG3 and UH3 phases of the project. These clinical trials are expected to be conducted with a high degree of efficiency, with streamlined administrative procedures wherever possible. Applicants are strongly encouraged to employ project management principles as appropriate. Applications that address contingency plans to proactively confront potential delays or disturbances in meeting the milestones are strongly encouraged. </p><p><strong>Phases of Award</strong></p><p>The UG3 phase will support the development of the protocol, manual of operations and procedures, case report forms, and other resources necessary to the performance of the trial; further development of study partnerships; finalization of the protocol and approval by a Data and Safety Monitoring Board (DSMB); and Single Institutional Review Board (see <a href="https://grants.nih.gov/grants/guide/notice-files/not-od-16-094.html">NOT-OD-16-094</a>) approvals of the trial protocol and informed consent(s)/assent(s); activation and training of clinical sites; and initiation of recruitment, which is expected to begin by the end of the UG3 phase. </p><p>For trials using an FDA regulated product and requiring an IND or IDE application to administer the product to humans, investigators must (1) secure IND authorization or IDE approval and (2) provide documentation of this authorization or approval to NHLBI before a funding decision will be made. Necessary drugs, devices, or other resources must be obtained by the end of the UG3 award to allow for the successful launch and execution of the proposed clinical trial in the UH3 phase. </p><p>Investigators and NHLBI will review and mutually agree upon the final revised milestones that will be included in the Terms and Conditions of the grant, if awarded. Transition to the UH3 phase is predicated on the successful completion of all core milestones proposed and peer-review for the UG3 phase of the application. The core milestones must be met during the UG3 phase to allow for successful launch of the full trial in the UH3 phase. The overall planned enrollment and percentage of active clinical sites expected by the end of the UG3 phase will be agreed upon between the recipient and the NHLBI prior to an award. Enrollment of participants into the clinical trial is expected to begin before the end of the UG3 phase to optimize the probability of successfully completing the trial on time and on budget. NHLBI will conduct an administrative review approximately 9 months into the UG3 phase to evaluate progress toward achievement of milestones included in the Notice of Award. Milestones and timelines for the UH3 phase may be revised and finalized at the time of the UG3/UH3 transition. Less than satisfactory progress in the UH3 phase may lead to closing out the award. </p><p>UH3 milestones must address timing of overall recruitment/enrollment and retention goals, including accrual goals for women, minorities, and individuals of all ages including children and older adults. It is expected that, if funded, both the CCC and DCC will be responsible for milestone completion but that only one party, the CCC or the DCC, will be responsible for recording the completion of both CCC and DCC milestones through <a href="http://econnect.nhlbi.nih.gov/econnect/">eConnect</a>, an NHLBI platform that facilitates transfer of electronic information to NHLBI. Subject to NHLBI funding availability and scientific priorities, UH3 awards will be made after administrative review with specific attention to the extent to which all agreed-upon milestones have been met. If the UH3 is funded, NHLBI will review the progress of the clinical trial on a regular basis. Slower than anticipated progress towards meeting milestones will result in a re-evaluation of the award by NHLBI, including whether the objectives of the trial can be met on time and on budget. If milestones have not been satisfactorily met, subsequent funding years may not be approved and may lead to closing out the award. </p><p>NHLBI policies regarding milestones and relevant clinical research/studies policies are described in the following: <a href="https://www.nhlbi.nih.gov/research/funding/human-subjects/accrual-guidelines">NHLBI Accrual of Human Subjects (Milestones) Policy</a>, <a href="http://www.nhlbi.nih.gov/research/funding/human-subjects/women-minority-policy">NHLBI Policy for Inclusion of Women and Minorities in Clinical Research</a>, <a href="http://www.nhlbi.nih.gov/research/funding/human-subjects/data-safety-monitoring-policy">NHLBI Policy for Data and Safety Monitoring of Extramural Clinical Studies,</a> <a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-094.html">NIH Single IRB Policy</a> and <a href="https://www.nhlbi.nih.gov/grants-and-training/policies-and-guidelines/nhlbi-policy-for-data-sharing"><u>NHLBI Supplement to the NIH Policy for Data Management and Sharing</u></a>.</p><p><strong>Note:</strong> This CCC NOFO runs in parallel with a companion NOFO (<a href="https://grants.nih.gov/grants/guide/pa-files/PAR-26-024.html">PAR-27-013</a>) for a collaborating Data Coordinating Center (DCC) application. Both a CCC application and a collaborating DCC application must be submitted on the same due date for consideration by NHLBI. CCC (UG3/UH3) applications submitted without a collaborative DCC (U24) application will be deemed incomplete and <strong>will not </strong>proceed to review.</p><p><strong>Clinical Studies Not Supported by and Non-Responsive to this NOFO</strong></p><p>The following types of clinical studies are not intended to be supported by this NOFO and will not proceed to peer review:</p><ul><li>Phase I (first-in-human) trials, whether single or multi-site</li><li>Single site trials</li><li>Drug or device safety trials</li><li>Multi-site observational studies that do not meet the NIH definition of a clinical trial (see <a href="https://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-611.html">NOT-HL-18-611</a>)</li><li>Mechanistic or Basic Experimental Studies in Humans (BESH) (<a href="https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-690.html">NOT-HL-19-690</a>)</li></ul><p><strong>Prior to Submission </strong><br>Applicants are <strong>strongly</strong> encouraged to consult with the Scientific/Research contacts for the area of science for which they are planning to develop an application <strong>prior to submission</strong> to confirm the NHLBI-specific clinical trial NOFO to which the application should be submitted. Early contact (at least 12 weeks prior to submission) is encouraged. This period of time provides an opportunity for NHLBI staff to discuss the scope and goals, and to provide information and guidance to potential applicants. </p>
</div>

<div data-element-id="261249" data-element-has-label="false" data-element-required="false" data-element-has-value="true" data-section-code="FOD" data-element-type="TEXT">
<a id='_bookmark261249' tabindex='-1' aria-hidden='true'></a><p>Investigators proposing NIH-defined clinical trials may refer to the <a href="https://researchmethodsresources.nih.gov/">Research Methods Resources</a> website for information about developing statistical methods and study designs.</p>
</div>

<div data-element-id="261250" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="FOD" data-element-type="TEXT">
<a id='_bookmark261250' tabindex='-1' aria-hidden='true'></a><p>See Section VIII. Other Information for award authorities and regulations.</p>
</div>

<div data-element-id="261251" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="AI" data-element-type="TEXT">
<a id='_bookmark261251' tabindex='-1' aria-hidden='true'></a><a name="_Section II. Award Information"></a><h2>Section II. Award Information</h2>
</div>

<div class="row" data-index="40">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261252" data-element-required="true" data-element-has-value="true" data-section-code="AI" data-element-type="TEXT">
<a id='_bookmark261252' tabindex='-1' aria-hidden='true'></a>Funding Instrument
</div>
<div class=" col-md-8 datacolumn">
<p>Cooperative Agreement: A financial assistance mechanism used when there will be substantial Federal scientific or programmatic involvement. Substantial involvement means that, after award, NIH scientific or program staff will assist, guide, coordinate, or participate in project activities. See Section VI.2 for additional information about the substantial involvement for this NOFO.</p>
</div>
</div>

<div class="row" data-index="41">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261253" data-element-required="true" data-element-has-value="true" data-section-code="AI" data-element-type="LINKED_ELEMENT">
<a id='_bookmark261253' tabindex='-1' aria-hidden='true'></a> Application Types Allowed
</div>
<div class=" col-md-8 datacolumn">
New
<br>
Resubmission
<br>
Revision
<br>
</div>
</div>

<div class="row" data-index="43">
<div class="col-md-push-4 col-md-8 datacolumn">
<a id='_bookmark261255' tabindex='-1' aria-hidden='true'></a><p>The <a href="http://grants.nih.gov/grants/guide/url_redirect.htm?id=11116">OER Glossary</a> and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.</p>
</div>
</div>

<div class="row" data-index="44">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261256" data-element-required="false" data-element-has-value="true" data-section-code="AI" data-element-type="TEXT">
<a id='_bookmark261256' tabindex='-1' aria-hidden='true'></a>Clinical Trial?
</div>
<div class=" col-md-8 datacolumn">
<p>Required: Only accepting applications that propose clinical trial(s).</p>
</div>
</div>

<div class="row" data-index="45">
<div class="col-md-push-4 col-md-8 datacolumn">
<a id='_bookmark261257' tabindex='-1' aria-hidden='true'></a><p><a href="https://grants.nih.gov/grants/guide/url_redirect.htm?id=82370">Need help determining whether you are doing a clinical trial?</a></p>
</div>
</div>

<div class="row" data-index="46">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261258" data-element-required="true" data-element-has-value="true" data-section-code="AI" data-element-type="TEXT">
<a id='_bookmark261258' tabindex='-1' aria-hidden='true'></a>Funds Available and Anticipated Number of Awards
</div>
<div class=" col-md-8 datacolumn">
<p class="Normal">The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.</p>
</div>
</div>

<div class="row" data-index="47">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261259" data-element-required="true" data-element-has-value="true" data-section-code="AI" data-element-type="TEXT">
<a id='_bookmark261259' tabindex='-1' aria-hidden='true'></a>Award Budget
</div>
<div class=" col-md-8 datacolumn">
<p>Application budgets are not limited but need to reflect the actual needs of the proposed project.</p>
</div>
</div>

<div class="row" data-index="48">
<div class="col-md-4 datalabel" tabindex="0" data-element-id="261260" data-element-required="true" data-element-has-value="true" data-section-code="AI" data-element-type="TEXT">
<a id='_bookmark261260' tabindex='-1' aria-hidden='true'></a>Award Project Period
</div>
<div class=" col-md-8 datacolumn">
<p>The scope of the proposed project should determine the requested project award period.</p><p>The project period for the UG3 phase will be up to 1 year.</p><p>The project period for the UH3 phase is expected to be 4 years. With strong justification, up to 6 years for the UH3 may be requested.</p>
</div>
</div>

<div data-element-id="261261" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="AI" data-element-type="TEXT">
<a id='_bookmark261261' tabindex='-1' aria-hidden='true'></a><p>NIH grants policies as described in the <a href="http://grants.nih.gov/grants/guide/url_redirect.htm?id=11120">NIH Grants Policy Statement</a> will apply to the applications submitted and awards made from this NOFO.</p>
</div>

<div data-element-id="261262" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="EI" data-element-type="TEXT">
<a id='_bookmark261262' tabindex='-1' aria-hidden='true'></a><a name="_Section III. Eligibility Information"></a><h2>Section III. Eligibility Information</h2>
</div>

<div data-element-id="261263" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="EI" data-element-type="TEXT">
<a id='_bookmark261263' tabindex='-1' aria-hidden='true'></a><h4>1. Eligible Applicants</p>
</div>

<div class="heading4" tabindex="0" data-element-id="261264" data-element-required="true" data-element-has-value="true" data-section-code="EI" data-element-type="TEXT">
<a id='_bookmark261264' tabindex='-1' aria-hidden='true'></a>Eligible Organizations
</div>

<div data-element-id="261264" data-element-has-label="true" data-element-required="true" data-element-has-value="true" data-section-code="EI" data-element-type="TEXT">
<p>Higher Education Institutions - Includes all types</p><ul><li>Public/State Controlled Institutions of Higher Education</li><li>Private Institutions of Higher Education</li></ul><p>Nonprofits Other Than Institutions of Higher Education</p><ul><li>Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)</li><li>Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)</li></ul><p>For-Profit Organizations</p><ul><li>Small Businesses</li><li>For-Profit Organizations (Other than Small Businesses)</li></ul><p>Local Governments</p><ul><li>State Governments</li><li>County Governments</li><li>City or Township Governments</li><li>Special District Governments</li><li>Indian/Native American Tribal Governments (Federally Recognized)</li><li>Indian/Native American Tribal Governments (Other than Federally Recognized).</li></ul>
</div>

<div data-element-id="261265" data-element-has-label="false" data-element-required="false" data-element-has-value="true" data-section-code="EI" data-element-type="TEXT">
<a id='_bookmark261265' tabindex='-1' aria-hidden='true'></a><p>Federal Governments</p>

<ul>
<li>Eligible Agencies of the Federal Government</li>
<li>U.S. Territory or Possession</li>
</ul>
</div>

<div data-element-id="261266" data-element-has-label="false" data-element-required="false" data-element-has-value="true" data-section-code="EI" data-element-type="TEXT">
<a id='_bookmark261266' tabindex='-1' aria-hidden='true'></a><p>Other</p>

<ul>
<li>Independent School Districts</li>
<li>Public Housing Authorities/Indian Housing Authorities</li>
<li>Native American Tribal Organizations (other than Federally recognized tribal governments)</li>
<li>Faith-based or Community-based Organizations</li>
<li>Regional Organizations</li>
<li>Non-domestic (non-U.S.) Entities (Foreign Organizations)</li>
</ul>
</div>

<div data-element-id="261268" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="EI" data-element-type="TEXT">
<a id='_bookmark261268' tabindex='-1' aria-hidden='true'></a><h4>Foreign Organizations/International Collaborations</h4>
</div>

<div data-element-id="261269" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="EI" data-element-type="RADIO_BUTTON">
<a id='_bookmark261269' tabindex='-1' aria-hidden='true'></a><p class="Normal">Non-domestic (non-U.S.) Entities (Foreign Organizations) <strong>are </strong>eligible to apply.</p>
</div>

<div data-element-id="261270" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="EI" data-element-type="RADIO_BUTTON">
<a id='_bookmark261270' tabindex='-1' aria-hidden='true'></a><p>Non-domestic (non-U.S.) components of U.S. Organizations <strong>are </strong>eligible to apply.</p>
</div>

<div data-element-id="261271" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="EI" data-element-type="RADIO_BUTTON">
<a id='_bookmark261271' tabindex='-1' aria-hidden='true'></a><p class="Normal">Foreign components, as <a href="http://grants.nih.gov/grants/guide/url_redirect.htm?id=11118">defined in the NIH Grants Policy Statement</a>, <b>are </b>allowed.</p>
</div>

<div data-element-id="262147" data-element-has-label="false" data-element-required="true" data-element-has-value="true" data-section-code="EI" data-element-type="TEXT">
<a id='_bookmark262147' tabindex='-1' aria-hidden='true'></a><p>NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.</p><p>Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or <a href="https://grants.nih.gov/grants/policy/nihgps/HTML5/section_1/1.2_definition_of_terms.htm">foreign components</a>, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.</p>
</div>

<div class="heading4" tabindex="0" data-element-id="261272" data-element-required="true" data-element-has-value="true" data-section-code="EI" data-element-type="TEXT">
<a id='_bookmark261272' tabindex='-1' aria-hidden='true'></a>Required Registrations
</div>

<div data-element-id="261272" data-element-has-label="true" data-element-required="true" data-element-has-value="true" data-section-code="EI" data-element-type="TEXT">
<p><strong>Applicant Organizations</strong></p>

<p>Applicant organizations must complete and maintain the following registrations as described in the How to Apply- Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. Failure to complete registrations in advance of a due date is not a valid reason for a late submission, please reference the <a href="http://grants.nih.gov/grants/guide/url_redirect.htm?id=82423">NIH Grants Policy Statement Section 2.3.9.2 Electronically Submitted Applications</a> for additional information.</p>

<ul>
<li><a href="https://grants.nih.gov/grants/guide/url_redirect.htm?id=82390">System for Award Management (SAM) –</a> Applicants must complete and maintain an active registration, <strong>which requires renewal at least annually</strong>. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.

<ul>
<li><a href="http://grants.nih.gov/grants/guide/url_redirect.htm?id=11176">NATO Commercial and Government Entity (NCAGE) Code</a> – Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM.</li>
<li>Unique Entity Identifier (UEI) - A UEI is issued as part of the SAM.gov registration process. The same UEI must be used for all registrations, as well as on the grant application.</li>
</ul>
</li>
<li><a href="https://grants.nih.gov/grants/guide/url_redirect.htm?id=11123">eRA Commons</a> - Once the unique organization identifier is established, organizations can register with eRA Commons in tandem with completing their Grants.gov registrations; all registrations must be in place by time of submi

Apply with Grantable Learn more

Focus Areas & Funding Uses

Fields of Work

$2,000,000 - $5,000,000

Deadline

April 13, 2026

Ready to apply for Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

Apply with Grantable Learn more

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Overview

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Details

Eligibility

Eligibility

Eligible Applicant Types

How to Apply

PAR-27-012-Full-Announcement.html

Focus Areas & Funding Uses

Fields of Work

Categories

Related Grants

Findable Accessible Interoperable Reusable Open Science

Fiscal Year 2026 Scientific Infrastructure Support for Consolidated Innovative Nuclear Research

Pilot Program to Increase Research Capacity at Historically Black Colleges and Universities and Other Minority-Serving Institutions

ROSES 2025: B.4 Space Weather Science Application Research-to-Operations-to-Research

Advanced Rehabilitation Research Training (ARRT) Program - Community Living and Participation

FY 2026 Implementation of the U.S. Integrated Ocean Observing System (IOOS)

Ready to apply for Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)?